These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2664886)

  • 101. Nitrous oxide has no effect in the treatment of alcohol withdrawal syndrome: a double-blind placebo-controlled randomized trial.
    Alho H; Methuen T; Paloheimo M; Seppä K; Strid N; Apter-Kaseva N; Tiainen J; Salaspuro M; Roine R
    J Clin Psychopharmacol; 2003 Apr; 23(2):211-4. PubMed ID: 12640227
    [No Abstract]   [Full Text] [Related]  

  • 102. A double-blind comparison of sulpiride with chlordiazepoxide in neurosis.
    Toru M; Moriya H; Yamamoto K; Shimazono Y
    Folia Psychiatr Neurol Jpn; 1976; 30(2):153-64. PubMed ID: 786820
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Nimodipine in human alcohol withdrawal syndrome--an open study.
    Altamura AC; Regazzetti MG; Porta M
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):37-40. PubMed ID: 2136211
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Varying rates of alcohol metabolism in relation to detoxification medication.
    Clothier J; Kelley JT; Reed K; Reilly EL
    Alcohol; 1985; 2(3):443-5. PubMed ID: 4026962
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Amytriptyline and chlordiazepoxide (Limbitrol) in depressive states in Nigerians--a double-blind study.
    Morakinyo VO
    Afr J Med Sci; 1970 Oct; 1(4):409-14. PubMed ID: 4940219
    [No Abstract]   [Full Text] [Related]  

  • 106. Activation levels, EEG, and behavioural responses.
    Schwarz-Ottersbach E; Goldberg L
    Int J Psychophysiol; 1986 May; 4(1):7-17. PubMed ID: 3721944
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Hazards associated with the use of benzodiazepines in alcohol detoxification.
    Hill A; Williams D
    J Subst Abuse Treat; 1993; 10(5):449-51. PubMed ID: 8246319
    [TBL] [Abstract][Full Text] [Related]  

  • 108. [Topographical distribution of slow sleep rhythms in children withdrawn from barbiturates (author's transl)].
    Findji F; Catani P
    Rev Electroencephalogr Neurophysiol Clin; 1981 Nov; 11(2):218-27. PubMed ID: 7323369
    [TBL] [Abstract][Full Text] [Related]  

  • 109. delta9-Tetrahydrocannabinol and the quasi morphine withdrawal syndrome.
    Chesher GB; Zaluzny SG; Jackson DM; Malor R
    Adv Biosci; 1978 Jul 22-23; 22-23():605-18. PubMed ID: 574471
    [No Abstract]   [Full Text] [Related]  

  • 110. Responders and nonresponders to chlordiazepoxide and placebo: a discriminant function analysis.
    Downing RW; Rickels K
    Prog Neuropsychopharmacol; 1980; 4(4-5):405-15. PubMed ID: 7012878
    [No Abstract]   [Full Text] [Related]  

  • 111. Chlordiazepoxide metabolite accumulation in liver disease.
    Barton K; Auld PW; Scott MG; Nicholls DP
    Med Toxicol Adverse Drug Exp; 1989; 4(1):73-6. PubMed ID: 2710011
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Side effect of chlordiazepoxide.
    Benor D
    J Clin Pharmacol J New Drugs; 1967; 7(3):180. PubMed ID: 5231435
    [No Abstract]   [Full Text] [Related]  

  • 113. Treatment of the Acute Alcohol Withdrawal State: A Comparison of Four Drugs.
    Sellers EM
    Alcohol Health Res World; 1995; 19(1):34-35. PubMed ID: 31798083
    [No Abstract]   [Full Text] [Related]  

  • 114. Beyond benzodiazepines: a meta-analysis and narrative synthesis of the efficacy and safety of alternative options for alcohol withdrawal syndrome management.
    Fluyau D; Kailasam VK; Pierre CG
    Eur J Clin Pharmacol; 2023 Sep; 79(9):1147-1157. PubMed ID: 37380897
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal.
    Holbrook AM; Crowther R; Lotter A; Cheng C; King D
    CMAJ; 1999 Mar; 160(5):649-55. PubMed ID: 10101999
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Metabolism of difebarbamate in man.
    Vachta J; Valter K; Siegfried B
    Eur J Drug Metab Pharmacokinet; 1990; 15(3):191-8. PubMed ID: 2253648
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Double blind study on the efficacy and safety of tetrabamate and chlordiazepoxide in the treatment of the acute alcohol withdrawal syndrome.
    Radouco-Thomas S; Garcin F; Guay D; Marquis PA; Chabot F; Huot J; Chawla S; Forest JC; Martin S; Stewart G
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):55-75. PubMed ID: 2664886
    [TBL] [Abstract][Full Text] [Related]  

  • 118. [Double-blind study of the efficacy of tetrabamate and tiapride in the treatment of alcohol deprivation syndrome].
    Santo Domingo Carrasco J; Bravo Ortiz MF; Barroso Cañizares A; Caballero Martín L
    Med Clin (Barc); 1985 Oct; 85(13):533-6. PubMed ID: 3908847
    [No Abstract]   [Full Text] [Related]  

  • 119. [Anxiolytic efficacy and tolerance of tetrabamate in anxious patients abusing alcohol. Multicenter double-blind versus placebo study].
    Lôo H; Guelfi JD; Malka R; Brion S; Cottin M; Gailledreau J; Raab A; Salfati M; Sarda A; Godchau M
    Encephale; 1986; 12(5):291-7. PubMed ID: 3545785
    [TBL] [Abstract][Full Text] [Related]  

  • 120. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
    Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.